Search alternatives:
significant challenges » significant challenge (Expand Search), significant changes (Expand Search)
challenges decrease » challenges case (Expand Search)
changes decrease » larger decrease (Expand Search), change increases (Expand Search)
largest decrease » larger decrease (Expand Search), marked decrease (Expand Search)
significant challenges » significant challenge (Expand Search), significant changes (Expand Search)
challenges decrease » challenges case (Expand Search)
changes decrease » larger decrease (Expand Search), change increases (Expand Search)
largest decrease » larger decrease (Expand Search), marked decrease (Expand Search)
-
401
-
402
Bar charts showing the numbers of significantly differentially expressed genes for the different contrasts.
Published 2025“…<p>The extent of the bar above and below 0 on the vertical axis indicates the numbers of significantly differentially expressed genes (DEGs; B-H <i><i>P</i></i><sub>adj.…”
-
403
-
404
-
405
Predicted behavioural expression of young (orange) and old (blue) individuals that do (treatment) or do not (control) receive an immune challenge.
Published 2024“…<p>(a) If an immune challenge causes sickness behaviour then we expect that young and old immune-challenged individuals will decrease their population-level average behavioural expression compared with controls with old individuals decreasing their behavioural expression more than young individuals. …”
-
406
-
407
-
408
-
409
-
410
Changes in the neutrophil count.
Published 2025“…The leukocyte and neutrophil counts of the patients in the bone pain group were significantly higher than those of the patients in the no bone pain group, P(WBC) = 0.001, P(ANC) = 0.002.…”
-
411
Changes in the platelet count.
Published 2025“…The leukocyte and neutrophil counts of the patients in the bone pain group were significantly higher than those of the patients in the no bone pain group, P(WBC) = 0.001, P(ANC) = 0.002.…”
-
412
-
413
-
414
-
415
-
416
Image 2_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.jpeg
Published 2025“…We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”
-
417
Image 1_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.jpeg
Published 2025“…We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”
-
418
Spatio-temporal changes in SDG under multi-scenario spatio-temporal scenarios.
Published 2025Subjects: -
419
Change in the genotypes of <i>ATM</i>, <i>ERCC1</i>, and <i>XRCC1</i>.
Published 2024“…As CWP progressed, the CC and CA genotypes of <i>ERCC1</i> rs3212986 decreased and increased significantly, respectively. …”
-
420